Telerehabilitation exercise program for Parkinson's (NCT06052280)
Improve gait and balance remotely
- Trial ID
- NCT06052280
- Official Title
- Management of Initial Parkinson's Disease: a Prospective, Mono-centric, no Profit Pilot Clinical Trial Comparing Conventional Face-to-face Physiotherapy and Home-based Telerehabilitation
- Goal
- Improve gait and balance remotely
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- Azienda Sanitaria Locale CN1 Cuneo
- Study Type
- INTERVENTIONAL
- Enrollment
- 40 participants
- Conditions
- Parkinson Disease
- Interventions
- Telerehabilitation exercise program, Home self-exercise program
Summary For Families
The goal is to see if home-based, therapist-led telerehabilitation can match or improve early Parkinson's management for mobility, balance and daily function compared with conventional physiotherapy or a self-directed home program. The telerehab arm delivers live, video-guided exercise sessions with real-time feedback and progression from a physiotherapist, while the home arm follows a prescribed self-exercise plan; both focus on strength, gait and balance and are meant to complement, not replace, medications like levodopa by helping you move better on your current drug regimen. The trial is looking for adults 18 and older with idiopathic Parkinson's at early stages (Hoehn and Yahr stage 2 or below), a MoCA score above 25, ability to consent and participate, and for the telerehab arm reliable home internet and about 2 meters of clear space in front of a device. People with atypical Parkinsonism or serious medical problems that would limit moderate exercise are excluded.
Locations
- Azienda Sanitaria Locale CN1, Cuneo, Italy
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Telerehabilitation exercise program. The goal is to see if home-based, therapist-led telerehabilitation can match or improve early Parkinson's management for mobility, balance and daily function compared with conventional physiotherapy or a self-directed home program. The telerehab arm delivers live, video-guided exercise sessions with real-time feedback and progression from a physiotherapist, while the home arm follows a prescribed self-exercise plan; both focus on strength, gait and balance and are meant to complement, not replace, medications like levodopa by helping you move better on your current drug regimen. The trial is looking for adults 18 and older with idiopathic Parkinson's at early stages (Hoehn and Yahr stage 2 or below), a MoCA score above 25, ability to consent and participate, and for the telerehab arm reliable home internet and about 2 meters of clear space in front of a device. People with atypical Parkinsonism or serious medical problems that would limit moderate exercise are excluded.
- Who can participate?
- Participants must be at least 18 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- You are never charged a fee to join a legitimate clinical trial, and the study treatment and study-specific tests are provided by the trial sponsor at no charge. In the US, routine care you would receive anyway can still be billed to you or your insurance; coverage rules differ by country, and trials in the UK and Canada usually run through public health systems. Travel, parking, and time are real costs, and some trials reimburse them while others do not. Before enrolling, ask the study coordinator to explain in writing what is and is not covered.
- How long does the trial last?
- This trial is estimated to last approximately 1 year.
- Can I leave the trial if I change my mind?
- Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
- Can my spouse or care partner come with me to visits?
- In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.
- Will I get a placebo in this trial?
- There is no placebo group. Everyone receives an active treatment; the study compares one treatment against another.